Ironwood Pharmaceuticals, Inc. (IRWD)

NASDAQ: IRWD · Real-Time Price · USD

3.820

+0.280 (7.91%)

At close: Jun 22, 2026, 4:00 PM EDT

3.820

0.00 (0.00%)

Pre-market: Jun 23, 2026, 4:01 AM EDT

Ironwood Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	629	550	710	1,789	1,908	1,889
Market Cap Growth	580.54%	-22.57%	-60.32%	-6.27%	1.01%	3.28%
Enterprise Value	1,006	931.85	1,221	2,412	1,668	1,745
Last Close Price	3.82	3.37	4.43	11.44	12.39	11.66
PE Ratio	6.19	22.47	443.00	-	12.91	3.63
Forward PE	3.38	7.84	13.42	14.14	11.24	8.43
PEG Ratio	-	-	-	1.98	2.25	1.21
PS Ratio	1.74	1.86	2.02	4.04	4.65	4.57
PB Ratio	-	-2.10	-2.36	-5.17	2.93	3.12
P/TBV Ratio	-	-	-	-	6.26	3.16
P/FCF Ratio	5.60	4.33	6.86	9.77	6.97	7.22
P/OCF Ratio	5.60	4.33	6.85	9.75	6.97	7.21
EV/Sales Ratio	2.78	3.15	3.47	5.45	4.06	4.22
EV/EBITDA Ratio	4.93	9.28	12.83	-	6.63	7.46
EV/EBIT Ratio	4.98	9.46	13.11	-	6.66	7.51
EV/FCF Ratio	8.96	7.34	11.80	13.17	6.10	6.67
Debt / Equity Ratio	-1.82	-1.51	-1.98	-1.48	0.63	0.59
Debt / EBITDA Ratio	2.96	5.96	6.30	-	1.65	2.04
Debt / FCF Ratio	5.32	4.71	5.80	3.91	1.52	1.82
Net Debt / Equity Ratio	-1.74	-1.46	-1.70	-1.80	-0.37	-0.24
Net Debt / EBITDA Ratio	1.87	3.81	5.37	-0.66	-0.95	-0.62
Net Debt / FCF Ratio	3.36	3.01	4.94	3.40	-0.88	-0.55
Asset Turnover	0.87	0.79	0.86	0.56	0.37	0.49
Quick Ratio	1.38	1.08	4.39	0.80	30.23	4.54
Current Ratio	1.41	1.13	4.69	0.84	30.58	4.61
Return on Equity (ROE)	-100.53%	-41.21%	-40.00%	-564.93%	52.42%	-38.03%
Return on Assets (ROA)	67.61%	43.65%	45.01%	-109.72%	29.37%	-17.45%
Return on Invested Capital (ROIC)	89.08%	59.10%	55.46%	-199.96%	70.72%	-43.89%
Return on Capital Employed (ROCE)	113.44%	42.21%	36.73%	-148.89%	24.54%	31.13%
Earnings Yield	16.25%	4.45%	0.23%	-	7.75%	27.53%
FCF Yield	17.84%	23.11%	14.57%	10.24%	14.34%	13.85%
Buyback Yield / Dilution	-2.82%	-1.81%	-2.99%	16.57%	-13.32%	-2.34%
Total Shareholder Return	-2.82%	-1.81%	-2.99%	16.57%	-13.32%	-2.34%

SEC Filings: 10-K · 10-Q